<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Atypon//DTD Atypon JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1.1 20160223//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName Atypon-archive-oasis-article1-mathml3.dtd?>
<?SourceDTD.Version 1.1.1?>
<?ConverterInfo.XSLTName atyponoasis-nisons2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">JCO Clin Cancer Inform</journal-id>
    <journal-id journal-id-type="iso-abbrev">JCO Clin Cancer Inform</journal-id>
    <journal-id journal-id-type="hwp">cci</journal-id>
    <journal-id journal-id-type="pmc">cci</journal-id>
    <journal-id journal-id-type="publisher-id">CCI</journal-id>
    <journal-title-group>
      <journal-title>JCO Clinical Cancer Informatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2473-4276</issn>
    <publisher>
      <publisher-name>American Society of Clinical Oncology</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7049249</article-id>
    <article-id pub-id-type="publisher-id">1900110</article-id>
    <article-id pub-id-type="doi">10.1200/CCI.19.00110</article-id>
    <article-categories>
      <subj-group subj-group-type="subjects">
        <compound-subject>
          <compound-subject-part content-type="code">Digital Healthcare</compound-subject-part>
          <compound-subject-part content-type="label">Big Data, Machine learning</compound-subject-part>
        </compound-subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Original Reports</subject>
        <subj-group>
          <subject>Special Series: Informatics Tools for Cancer Research and Care</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Exploring Integrative Analysis Using the BioMedical Evidence Graph</article-title>
      <alt-title alt-title-type="short">The BioMedical Evidence Graph</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Struck</surname>
          <given-names>Adam</given-names>
        </name>
        <degrees>MSc</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Walsh</surname>
          <given-names>Brian</given-names>
        </name>
        <degrees>BS</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Buchanan</surname>
          <given-names>Alexander</given-names>
        </name>
        <degrees>BS</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lee</surname>
          <given-names>Jordan A.</given-names>
        </name>
        <degrees>MS</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Spangler</surname>
          <given-names>Ryan</given-names>
        </name>
        <degrees>MS</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Stuart</surname>
          <given-names>Joshua M.</given-names>
        </name>
        <degrees>PhD</degrees>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <xref ref-type="corresp" rid="cor1"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ellrott</surname>
          <given-names>Kyle</given-names>
        </name>
        <degrees>PhD</degrees>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <aff id="aff1"><label><sup>1</sup></label>Biomedical Engineering, Oregon Health and Science University, Portland OR</aff>
      <aff id="aff2"><label><sup>2</sup></label>Biomolecular Engineering Department, University of California, Santa Cruz, Santa Cruz, CA</aff>
      <aff id="aff3"><label><sup>3</sup></label>University of California Santa Cruz Genomics Institute, University of California, Santa Cruz Santa Cruz, CA</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1">Joshua M. Stuart, PhD, UC Santa Cruz Genomics Institute, University of California, Santa Cruz, 1156 High St, Santa Cruz, CA 95064; e-mail: <email>jstuart@soe.ucsc.edu</email>.</corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>25</day>
      <month>2</month>
      <year>2020</year>
    </pub-date>
    <volume>4</volume>
    <elocation-id>CCI.19.00110</elocation-id>
    <history>
      <date date-type="accepted">
        <day>16</day>
        <month>1</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2020 by American Society of Clinical Oncology</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>American Society of Clinical OncologyCC-BY</copyright-holder>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <license-p>Licensed under the Creative Commons Attribution 4.0 License: <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link></license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:title="pdf" xlink:href="CCI.19.00110.pdf"/>
    <abstract>
      <sec>
        <title>PURPOSE</title>
        <p>The analysis of cancer biology data involves extremely heterogeneous data sets, including information from RNA sequencing, genome-wide copy number, DNA methylation data reporting on epigenetic regulation, somatic mutations from whole-exome or whole-genome analyses, pathology estimates from imaging sections or subtyping, drug response or other treatment outcomes, and various other clinical and phenotypic measurements. Bringing these different resources into a common framework, with a data model that allows for complex relationships as well as dense vectors of features, will unlock integrated data set analysis.</p>
      </sec>
      <sec>
        <title>METHODS</title>
        <p>We introduce the BioMedical Evidence Graph (BMEG), a graph database and query engine for discovery and analysis of cancer biology. The BMEG is unique from other biologic data graphs in that sample-level molecular and clinical information is connected to reference knowledge bases. It combines gene expression and mutation data with drug-response experiments, pathway information databases, and literature-derived associations.</p>
      </sec>
      <sec>
        <title>RESULTS</title>
        <p>The construction of the BMEG has resulted in a graph containing &gt; 41 million vertices and 57 million edges. The BMEG system provides a graph query–based application programming interface to enable analysis, with client code available for Python, Javascript, and R, and a server online at bmeg.io. Using this system, we have demonstrated several forms of cross–data set analysis to show the utility of the system.</p>
      </sec>
      <sec>
        <title>CONCLUSION</title>
        <p>The BMEG is an evolving resource dedicated to enabling integrative analysis. We have demonstrated queries on the system that illustrate mutation significance analysis, drug-response machine learning, patient-level knowledge-base queries, and pathway level analysis. We have compared the resulting graph to other available integrated graph systems and demonstrated the former is unique in the scale of the graph and the type of data it makes available.</p>
      </sec>
    </abstract>
    <counts>
      <fig-count count="3"/>
      <table-count count="2"/>
      <equation-count count="0"/>
      <ref-count count="64"/>
      <page-count count="13"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name> SJS Export </meta-name>
        <meta-value>v1</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="s1">
    <title>INTRODUCTION</title>
    <p>Biological data produced by large-scale projects now routinely reach petabyte levels thanks to major advances in sequencing and imaging. With multiple profiling methods, platforms, versions, formats, and pipelines, a major unaddressed issue is querying across the increasingly heterogeneous data. When faced with the substantial labor and computation costs, researchers may use outdated and/or only a fraction of publicly available data.</p>
    <p>Graph databases are useful tools for integrating complex and interconnected data.<sup><xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref></sup> In the commercial sector, several major data aggregators have successfully used graph databases to integrate heterogeneous data. Facebook (Menlo Park, CA) uses the “Social Graph”<sup><xref rid="B4" ref-type="bibr">4</xref></sup> to represent the connections between people and their information, whereas Google’s search engine (Alphabet, Mountain View, CA) uses Google’s “Knowledge Graph” to connect various facts about different subjects. On the basis of these observations, we have built the BioMedical Evidence Graph (BMEG) to allow for complex integration and analysis of heterogeneous biological data.</p>
    <p>The BMEG was created by importing several cancer-related resources and transforming them into a coherent graph representation. These resources include patient and sample information, mutations, gene expression, drug response data, genomic annotations, and literature-based analysis (Appendix <xref rid="TA.1" ref-type="table">Table A1</xref>). The BMEG contains data on 15,000 patients, 52,000 samples, 6.8 million alleles, 640,000 drug-response experiments, and 50,000 literature-derived genotype-to-phenotype associations.</p>
    <p>We describe a resource that enables analysts to quickly access data from multiple sources and perform queries that integrate them with clear graph-based semantics. Independently, a researcher would need to download hundreds of files, write multiple file parsers, develop an integrated data model, map identifier systems, and normalize analytical results. The BMEG centralizes that work and makes it searchable using a full-feature query engine. To enable analysis and machine learning, the BMEG includes high-quality feature-extraction methods applied consistently to all samples. This includes the results provided by the best methods of somatic variant calling and RNA-sequencing analysis for cancer genomic and transcriptomic data sets. We used open challenges to create leaderboards of the best methods from all of those submitted by the community. We then participated in the development of open standards to enable the exchange of genomic associations from cancer knowledge bases. Finally, we implemented computational integrity checks and unit tests for each of the data import modules.</p>
    <boxed-text id="b1" position="anchor" orientation="portrait">
      <sec>
        <title>CONTEXT</title>
        <list list-type="simple" id="L1">
          <list-item>
            <p>
              <bold>Key Objective</bold>
            </p>
          </list-item>
          <list-item>
            <p>Can a graph database help researchers access multiple integrated data sets for cancer omics analysis?</p>
          </list-item>
          <list-item>
            <p>
              <bold>Knowledge Generated</bold>
            </p>
          </list-item>
          <list-item>
            <p>We have developed and tested an integrated graph database, BioMedical Evidence Graph, that connects patient sample data, cell-line drug-response data, and multiple knowledge bases. Simple queries to this system allowed cross–data set analysis in seconds when the same questions would have required days or weeks of manual effort otherwise.</p>
          </list-item>
          <list-item>
            <p>
              <bold>Relevance</bold>
            </p>
          </list-item>
          <list-item>
            <p>Analysis of cancer systems biology data requires a large variety of different kinds of data. The BioMedical Evidence Graph system provides a uniform interface for data interrogation that will make it easier to pose a variety of clinically relevant queries.</p>
          </list-item>
        </list>
      </sec>
    </boxed-text>
  </sec>
  <sec sec-type="methods" id="s2">
    <title>METHODS</title>
    <sec id="s3">
      <title>Graph Schema</title>
      <p>At the core of BMEG’s metadata is a tree representing the organization of all the different data elements (<xref ref-type="fig" rid="f1">Fig 1</xref>). <italic>Program</italic> node represents the root of the tree, defining a cohort of samples studied by a consortium. For example, The Cancer Genome Atlas (TCGA; National Cancer Institute, Bethesda, MD) is one such “program” and cohorts for different tumor types can be selected using the program’s child node called “Project.” Each tumor type is then populated by a number of <italic>Case</italic> nodes, which in turn have multiple <italic>Sample</italic> nodes, which can then be subdivided into a number of <italic>Aliquot</italic> nodes. The BMEG schema builds on this base structure to include data from a number of additional sources including: (1) genome reference, (2) gene and pathway annotations, (3) somatic variants, (4) gene expression data, and (5) knowledge bases.</p>
      <fig id="f1" fig-type="figure" orientation="portrait" position="float">
        <label>FIG 1.</label>
        <caption>
          <p>The BioMedical Evidence Graph schema showing the vertex types and connections of the graph. Numbers on vertices represent the total instances of a specific type defined by the vertex (eg, the Gene vertex includes 63,677 distinct protein-coding, microRNAs, and other gene entries); numbers on an edge connecting two vertices represent the total connections between any instance of the first vertex to any instance of the second vertex (eg, there are 214,804 connections from transcripts to the genes that encode them). Pfam, protein families.</p>
        </caption>
        <graphic xlink:href="CCI.19.00110f1"/>
      </fig>
    </sec>
    <sec id="s4">
      <title>Data Sources</title>
      <p>Initial data sources (Appendix <xref rid="TA.1" ref-type="table">Table A1</xref>) for the BMEG were centered on large cohorts of patient-derived samples, with DNA and RNA profiling, cell lines with drug-response data, and literature-derived drug-phenotype associations. The goal was to provide uniform input data for analysis and machine learning.</p>
    </sec>
    <sec id="s5">
      <title>RNA-Sequencing Data</title>
      <p>To identify the best methods for RNA analysis, we launched the somatic mutation calling–RNA challenge, which benchmarked isoform quantification methods to prioritize the methods used for processing data that would be ingested into the BMEG. For example, for transcript abundances we used results from Kallisto (Patcher Lab, University of California, Berkeley, Berkeley, CA), a top contending method in the somatic mutation calling–RNA challenge, to process the TCGA and Cancer Cell Line Encyclopedia (CCLE)<sup><xref rid="B5" ref-type="bibr">5</xref></sup> data sets. In addition, the Genotype-Tissue Expression project (National Institutes of Health, Bethesda, MD)<sup><xref rid="B6" ref-type="bibr">6</xref></sup> provided gene-level, transcript-per-million-mapped reads estimates for normal tissues that could be contrasted with tumors. Combinations of these resources provide 36,000 vertices to the BMEG graph.</p>
    </sec>
    <sec id="s6">
      <title>TCGA Metadata</title>
      <p>The Genomic Data Commons (GDC; National Cancer Institute, Bethesda, MD) created a data system to track the clinical and administrative meta-data of the TCGA samples and files. We used their web application programming interface (API) to obtain TCGA patient and sample metadata for the evidence graph.</p>
    </sec>
    <sec id="s7">
      <title>TCGA Genomic Data</title>
      <p>To determine the best methods for somatic mutation calling, we partnered with the Dialogue on Reverse Engineering Assessment of Methods (DREAM) consortium, Sage BioNetworks (Seattle, WA), and the Ontario Institute for Cancer Research to launch the International Cancer Genome Consortium–TCGA Somatic Mutation Calling challenge.<sup><xref rid="B7" ref-type="bibr">7</xref></sup> Many methods evaluated by this effort were incorporated into pipelines that would be deployed on the TCGA’s 10,000 exomes as part of the Multi-Center Mutation Calling in Multiple Cancers (MC3) project.<sup><xref rid="B8" ref-type="bibr">8</xref></sup> The MC3 adds 10,000 vertices that connect to 3 million alleles (2.6 million distinct alleles) in the graph. For the set of copy-number alteration events, we used the Gistic2<sup><xref rid="B9" ref-type="bibr">9</xref></sup> data from the Broad Institute’s Firehose system (Massachusetts Institute of Technology, Cambridge, MA).</p>
    </sec>
    <sec id="s8">
      <title>Cell-Line Drug-Response Data</title>
      <p>Cell-line clinical attributes and drug-response data has been collated by the DepMap (Broad Institute)<sup><xref rid="B10" ref-type="bibr">10</xref></sup> and Pharmacodb (BHKLAB, Princess Margaret Cancer Centre – University Health Network, Toronto, ON, Canada)<sup><xref rid="B11" ref-type="bibr">11</xref></sup> projects, respectively. This includes response curves, half maximal inhibitory concentration and half maximal effective concentration (EC<sub>50</sub>) scores from CCLE,<sup><xref rid="B12" ref-type="bibr">12</xref></sup> Cancer Therapeutics Response Portal (CTRP)<sup><xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref></sup> and Genomics of Drug Sensitivity in Cancer.<sup><xref rid="B15" ref-type="bibr">15</xref></sup> In addition, the DepMap and Cell Model Passports (Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK)<sup><xref rid="B16" ref-type="bibr">16</xref></sup> provided variant calls for a number of cell lines.</p>
    </sec>
    <sec id="s9">
      <title>Variant Drug Associations</title>
      <p>The Genotype To Phenotype (G2P; Wellcome Sanger Institute) schema<sup><xref rid="B17" ref-type="bibr">17</xref></sup> was designed to enable several different cancer knowledge-base resources to be aggregated into a coherent resource. The entries from these knowledge bases typically demarcate associations such as “the T41A mutation in <italic>CTNNB1</italic> causes sensitivity to imatinib.” With this resource, the BMEG has aggregated associations from six prominent cancer knowledge bases, including 50,000 associations vertices.</p>
    </sec>
    <sec id="s10">
      <title>Pathway Data</title>
      <p>Pathway Commons (<ext-link ext-link-type="uri" xlink:href="https://www.pathwaycommons.org/">https://www.pathwaycommons.org/</ext-link>)<sup><xref rid="B18" ref-type="bibr">18</xref></sup> aggregates, normalizes, and integrates data from 22 public pathway databases. At 1.5 million interactions and 400,000 detailed biochemical reactions, it is the largest curated pathway database available. It aggregates pathway relationships from Reactome (Wellcome Sanger Institute; European Molecular Biology Laboratory, Heidelberg, Germany),<sup><xref rid="B19" ref-type="bibr">19</xref></sup> NCI Pathway Interaction Database (National Cancer Institute),<sup><xref rid="B20" ref-type="bibr">20</xref></sup> PhosphoSitePlus (Cell Signaling Technology, Danvers, MA),<sup><xref rid="B21" ref-type="bibr">21</xref></sup> HumanCyc (SRI International, Menlo Park, CA),<sup><xref rid="B22" ref-type="bibr">22</xref></sup> PANTHER Pathway,<sup><xref rid="B23" ref-type="bibr">23</xref></sup> MSigDB (Broad Institute, Massachusetts Institute of Technology, Cambridge, MA),<sup><xref rid="B24" ref-type="bibr">24</xref></sup> Recon X,<sup><xref rid="B25" ref-type="bibr">25</xref></sup> Comparative Toxicogenomics Database (North Carolina State University, Raleigh, NC),<sup><xref rid="B26" ref-type="bibr">26</xref></sup> KEGG Pathway (Kyoto University, Kyoto, Japan),<sup><xref rid="B27" ref-type="bibr">27</xref></sup> Integrating Network Objects with Hierarchies,<sup><xref rid="B28" ref-type="bibr">28</xref></sup> NetPath (SolarWinds Worldwide, Austin, TX),<sup><xref rid="B29" ref-type="bibr">29</xref></sup> and WikiPathways.<sup><xref rid="B30" ref-type="bibr">30</xref></sup> Once loaded into the graph, these resources provided approximately 2 million vertices that could be queried by the user.</p>
    </sec>
    <sec id="s11">
      <title>Reference Data</title>
      <p>The BMEG uses Ensembl identifiers<sup><xref rid="B31" ref-type="bibr">31</xref></sup> as a global identifier to unite various genomic components present across the ingested biologic reference data and experimental results. The genomic annotations from Ensembl were modeled into the graph to provide a consistent chromosomal coordinate system for any sequence-level sample information. Part of the import pipeline includes annotating sample variants using Variant Effect Predictor<sup><xref rid="B32" ref-type="bibr">32</xref></sup> to connect them to gene, transcript, and exon data from Ensembl. These, in turn, link to Protein and Pfam (protein family)<sup><xref rid="B33" ref-type="bibr">33</xref></sup> assignments, as well as Gene Ontology<sup><xref rid="B34" ref-type="bibr">34</xref></sup> functional annotations.</p>
    </sec>
    <sec id="s12">
      <title>Queries Using a Graph Language</title>
      <p>To enable various analytical queries and provide a framework for analysts to build custom queries, we developed the Graph Integration Platform (GRIP) to design queries to use the BMEG. GRIP stores multiple forms of data and has the ability to hold thousands of data elements per vertex and per edge of the graph. This allows it to store sparse relationship data, such as pathways and ontologies, as well as dense matrix-formatted data, such as expression levels for thousands of genes across hundreds of samples.</p>
      <p>The query language implements most operations needed for subgraph selection, as well as aggregation of features. A general purpose end point places more emphasis on the client side, building smart queries to obtain the data they need rather than having custom server-side components provide specialized facets. Because of this, clients can easily create new queries, unanticipated by the server developers, that still have the correct desired effect. The API is available via Python (Python Software Foundation, Wilmington, DE), Javascript (PluralSight, Farmington, UT), and R (R Foundation, <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>) clients.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="s13">
    <title>RESULTS</title>
    <p>To test the utility of the BMEG and its query engine, we have crafted example queries that traverse different parts of the graph, to demonstrate how the system can quickly provide an analyst with connected data. Although it would be possible for an analyst to find the solutions to the following exercises without using the BMEG, the analyst would need to download and merge data from multiple different repositories such as from the TCGA’s GDC system, somatic mutations predicted from Broad Institute’s CCLE collection and the TCGA’s MC3 variant-calling project, seven different somatic variant-to-phenotype association catalogs, PubChem for the names and modes of action of molecular compounds, pathway gene sets from Pathway Commons, and three different drug-response databases. Thus, the benefits of ingesting all into a uniform graph data structure should provide a more seamless presentation that users will find easier to use once the API becomes familiar.</p>
    <p>The GRIP Query Language is a traversal-based graph-selection language inspired by Gremlin.<sup><xref rid="B35" ref-type="bibr">35</xref></sup> The user describes a series of steps that will be undertaken by a “traveler.” An example traversal would start on a vertex with label <italic>Project</italic>, move to edges labeled <italic>samples</italic>, then move along edges labeled <italic>aliquots</italic>. The engine then scans the graph for all valid paths that can be completed given the instructions. Each of the traversal instructions is based on the graph schema seen in <xref ref-type="fig" rid="f1">Figure 1</xref>. The commands are written using the Python version of the client, but they could be executed similarly in R or Javascript. These queries can be visualized as paths traversed through the BMEG graph (<xref ref-type="fig" rid="f2">Fig 2</xref>).</p>
    <fig id="f2" fig-type="figure" orientation="portrait" position="float">
      <label>FIG 2.</label>
      <caption>
        <p>Example queries. A diagram showing how each of the different queries described in this article traverse the graph. Each separate query is labeled by the example number in the text.</p>
      </caption>
      <graphic xlink:href="CCI.19.00110f2"/>
    </fig>
    <p>We begin with an example that counts the mutations per gene in a cancer cohort. This is a useful statistic to gauge one aspect of whether a gene may be a driver of progression, as evidenced by its prevalence in a subpopulation (in this case, breast cancer). As seen in example 1 in the following section, the query starts on a breast cancer project node (TCGA-BRCA) then traverses to the <italic>Case</italic>, <italic>Sample</italic>, and <italic>Aliquot</italic> nodes while filtering out any data properties that do not belong to the previous node information. As it passes the <italic>Sample</italic> node, it filters for tumor samples. Once on the <italic>Aliquot</italic> node, it continues to the <italic>SomaticCallset</italic>, which represents sets of variants produced by a single mutation calling analysis. The traversal then identifies the edges that connect the <italic>SomaticCallset</italic> to different alleles, this time using the <italic>outE</italic> command to land on the edge rather than the destination vertex. With the gene identifier in hand, it then uses the <italic>aggregate</italic> method to count the various terms that occur in the <italic>ensembl_gene</italic> field.</p>
    <sec id="s14">
      <title>Example 1: Count Mutations per Gene in Breast Cancer</title>
      <sec id="s15">
        <title>Query.</title>
        <p>For example 1, the query is written as follows:</p>
        <list list-type="bullet" id="L2">
          <list-item>
            <p>G.query().V(“Project:TCGA-BRCA”)</p>
          </list-item>
          <list-item>
            <p>.out(“cases”).out(“samples”)</p>
          </list-item>
          <list-item>
            <p>.has(gripql.eq(“gdc_attributes.sample_type”, “Primary Tumor”))</p>
          </list-item>
          <list-item>
            <p>.out(“aliquots”).out(“somatic_callsets”).outE(“alleles”)</p>
          </list-item>
          <list-item>
            <p>.has(gripql.contains(“methods”, “MUTECT”))</p>
          </list-item>
          <list-item>
            <p>.aggregate(gripql.term(“geneCount”, “ensembl_gene”))</p>
          </list-item>
        </list>
      </sec>
      <sec id="s16">
        <title>Result.</title>
        <p>The result lists the number of variant alleles found for each gene. The example accesses data from the GDC as well as the MC3 somatic variant call set:</p>
        <list list-type="bullet" id="L3">
          <list-item>
            <p>ENSG00000155657 (n = 416)</p>
          </list-item>
          <list-item>
            <p>ENSG00000121879 (n = 401)</p>
          </list-item>
          <list-item>
            <p>ENSG00000141510 (n = 300)</p>
          </list-item>
          <list-item>
            <p>ENSG00000181143 (n = 193)</p>
          </list-item>
          <list-item>
            <p>ENSG00000198626 (n = 113)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s17">
      <title>Example 2: Identify Pathways Containing Mutated Genes</title>
      <p>There may be a theme among the most frequently mutated genes in breast cancer. The next two example queries address this by finding the most frequently affected pathways. First, example 2 identifies pathways containing mutated genes. Example 3 tallies the number of genes per pathway. To identify the pathways involved in mutations, the example derives a list of all mutated genes, finds their associated pathways, and retrieves the tuples of every gene-pathway pair, using the <italic>as_</italic> command (the underscore is added to avoid clashing with the Python-reserved word <italic>as</italic>) to store the gene and then using the <italic>render</italic> function to display only the needed data.</p>
      <sec id="s18">
        <title>Query.</title>
        <list list-type="bullet" id="L4">
          <list-item>
            <p>G.query().V(genes).as_(“gene”)</p>
          </list-item>
          <list-item>
            <p>.out(“pathways”).render([“$gene._gid”, “$._gid”])</p>
          </list-item>
        </list>
      </sec>
      <sec id="s19">
        <title>Result.</title>
        <p>The result returns all the pathways for which each gene is a member. This query uses data extracted from Ensembl and Pathway Commons.</p>
        <list list-type="bullet" id="L5">
          <list-item>
            <p>ENSG00000000419 (pathwaycommons.org/pc11/Pathway_6bf6d39c0284b6...)</p>
          </list-item>
          <list-item>
            <p>ENSG00000000938 (identifiers.org/reactome/<italic>R</italic>-HSA-432142)</p>
          </list-item>
          <list-item>
            <p>ENSG00000000971 (identifiers.org/reactome/<italic>R</italic>-HSA-977606)</p>
          </list-item>
          <list-item>
            <p>ENSG00000001036 (pathwaycommons.org/pc11/Pathway_4b5817426aa06d...)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s20">
      <title>Example 3: Determine the Number of Mutations in Each Pathway</title>
      <p>Continuing in this investigation to derive the most affected pathways, the next step is to aggregate the mutations per pathway and then sum them. To do this, the preceding listed information can be combined with the previously found result tabulating the mutations per pathway. To sum all the mutations in all the genes in a particular pathway, the traversal starts on the <italic>Pathway</italic> vertex marked for later retrieval using the <italic>as_</italic> command. Once the traveler has split and moved out to the multiple child <italic>Gene</italic> vertices, the <italic>select</italic> command recalls the stored pathway vertex and moves the traveler back. At this point, an <italic>aggregation</italic> is called to count the number of travelers on each <italic>Pathway</italic> vertex.</p>
      <sec id="s21">
        <title>Query.</title>
        <list list-type="bullet" id="L6">
          <list-item>
            <p>G.query().V().hasLabel(“Pathway”).as_(“pathway”)</p>
          </list-item>
          <list-item>
            <p>.out(“genes”).select(“pathway”)</p>
          </list-item>
          <list-item>
            <p>.aggregate(gripql.term(“pathwayGeneCount”, “_gid”))</p>
          </list-item>
        </list>
      </sec>
      <sec id="s22">
        <title>Result.</title>
        <p>The result lists the number of mutations for each pathway found.</p>
        <list list-type="bullet" id="L7">
          <list-item>
            <p>identifiers.org/reactome/<italic>R</italic>-HSA-191273 (n = 439)</p>
          </list-item>
          <list-item>
            <p>identifiers.org/reactome/<italic>R</italic>-HSA-381753 (n = 393)</p>
          </list-item>
          <list-item>
            <p>identifiers.org/reactome/<italic>R</italic>-HSA-212436 (n = 341)</p>
          </list-item>
          <list-item>
            <p>pathwaycommons.org/pc11/Pathway_4b5817426aa06d... (n = 340)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s23">
      <title>Example 4: Find Publications Relevant to Phenotypic Consequences of Mutations</title>
      <p>A biologist may wish to find evidence in the literature for any known phenotypic consequences of a collection of mutations, providing clues about the mechanisms involved in carcinogenesis. To this end, example 4 shows how the mutations found in the Breast Cancer Carcinoma (BRCA) cohort are linked to publications referenced by the G2P associations. In this use case, the aggregate method is called on the <italic>_gid</italic> variable, which represents a unique global identifier for each vertex.</p>
      <sec id="s24">
        <title>Query.</title>
        <list list-type="bullet" id="L8">
          <list-item>
            <p>G.query().V(“Project:TCGA-BRCA”)</p>
          </list-item>
          <list-item>
            <p>.out(“cases”).out(“samples”)</p>
          </list-item>
          <list-item>
            <p>.has(gripql.eq(“gdc_attributes.sample_type”, “Primary Tumor”))</p>
          </list-item>
          <list-item>
            <p>.out(“aliquots”).out(“somatic_callsets”).out(“alleles”)</p>
          </list-item>
          <list-item>
            <p>.out(“g2p_associations”).out(“publications”)</p>
          </list-item>
          <list-item>
            <p>.aggregate(gripql.term(“pub”, “_gid”))</p>
          </list-item>
        </list>
      </sec>
      <sec id="s25">
        <title>Result.</title>
        <p>The result returns a list of the number of mutations for all genes connected in each of the returned papers. This query connects data from the GDC, the knowledge bases imported from the G2P project, and PubMed.</p>
        <list list-type="bullet" id="L9">
          <list-item>
            <p>Publication:ncbi.nlm.nih.gov/pubmed/27269946 (n = 1,033)</p>
          </list-item>
          <list-item>
            <p>Publication:ncbi.nlm.nih.gov/pubmed/27174596 (n = 1,029)</p>
          </list-item>
          <list-item>
            <p>Publication:ncbi.nlm.nih.gov/pubmed/19223544 (n = 858)</p>
          </list-item>
          <list-item>
            <p>Publication:ncbi.nlm.nih.gov/pubmed/20619739 (n = 664)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s26">
      <title>Example 5: Find Drugs Described in the Literature to Treat Phenotypes Linked to Mutations</title>
      <p>The phenotypes in the G2P associations, linked to the collected breast cancer mutations, may be associated with drugs that treat specific conditions. Example 5 defines a traversal of the graph to uncover compounds linked to phenotypes on the basis of specific alleles. The traversal is much like the one illustrated in example 4; however, it also includes a <italic>distinct</italic> operation to identify unique pairs of cases and compounds. If there are multiple known association records from different publications and these publications link one allele to the same drug-response phenotype, then only one relationship will be noted per patient.</p>
      <sec id="s27">
        <title>Query.</title>
        <list list-type="bullet" id="L10">
          <list-item>
            <p>G.query().V(“Project:TCGA-BRCA”)</p>
          </list-item>
          <list-item>
            <p>.out(“cases”).as_(“case”).out(“samples”)</p>
          </list-item>
          <list-item>
            <p>.has(gripql.eq(“gdc_attributes.sample_type”,“Primary Tumor”))</p>
          </list-item>
          <list-item>
            <p>.out(“aliquots”).out(“somatic_callsets”).out(“alleles”)</p>
          </list-item>
          <list-item>
            <p>.out(“g2p_associations”).out(“compounds”)</p>
          </list-item>
          <list-item>
            <p>.distinct([“$case._gid”, “_gid”])</p>
          </list-item>
          <list-item>
            <p>.aggregate(gripql.term(“compound”, “_gid”))</p>
          </list-item>
        </list>
      </sec>
      <sec id="s28">
        <title>Result.</title>
        <p>The result lists the number of times compounds were associated to mutations in patients. This query uses data in the graph derived from the GDC, the MC3 callset, the G2P knowledge bases and PubChem.</p>
        <list list-type="bullet" id="L11">
          <list-item>
            <p>Compound:CID104741 (n = 345)</p>
          </list-item>
          <list-item>
            <p>Compound:CID11717001 (n = 340)</p>
          </list-item>
          <list-item>
            <p>Compound:CID56649450 (n = 327)</p>
          </list-item>
          <list-item>
            <p>Compound:NO_ONTOLOGY:CID24989044 (n = 313)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s29">
      <title>Example 6: Find Drugs Tested in Breast Cancer Cell Lines</title>
      <p>Taking the analysis one step further, the next two examples identify drugs proven effective against breast cancer cell lines as determined in the CTRP project. Example 6 identifies those compounds that have been tested in breast cancer cell lines as part of the CTRP project. The query uses the drugs found in example 5 through a list named <italic>compounds</italic> as a starting point.</p>
      <sec id="s30">
        <title>Query.</title>
        <list list-type="bullet" id="L12">
          <list-item>
            <p>G.query().V(compounds).as_(“compound”).out(“projects”)</p>
          </list-item>
          <list-item>
            <p>.has(gripql.eq(“project_id”, “CTRP_Breast_Cancer”))</p>
          </list-item>
          <list-item>
            <p>.select(“compound”).render([“_gid”, “synonym”])</p>
          </list-item>
        </list>
      </sec>
      <sec id="s31">
        <title>Result.</title>
        <p>The result lists those drugs that were profiled in the CTRP effort. For example, at the top of the list, one finds that the compound fulvestrant has been tested against breast cancer cell lines in the CTRP project.</p>
        <list list-type="bullet" id="L13">
          <list-item>
            <p>Compound:CID104741: FULVESTRANT</p>
          </list-item>
          <list-item>
            <p>Compound:CID11717001: CHEMBL525191</p>
          </list-item>
          <list-item>
            <p>Compound:CID17755052: PICTILISIB</p>
          </list-item>
          <list-item>
            <p>Compound:CID24964624: CHEMBL1079175</p>
          </list-item>
          <list-item>
            <p>Compound:CID42611257: VEMURAFENIB</p>
          </list-item>
          <list-item>
            <p>Compound:CID56649450: ALPELISIB</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s32">
      <title>Example 7: Find the Sensitivity of Breast Cancer Cell Lines to a Drug</title>
      <p>To get a sense of the effectiveness of each of these drugs, a natural extension of this line of inquiry is to find out how sensitive the cells are to them. The EC<sub>50</sub> measures the concentration achieving a response midway between the baseline and maximum when cells are exposed to a drug. It is a widely used measure of sensitivity (although a measure, GR<sub>50</sub>, that factors in growth rate, has been shown to be more useful) and available for compounds tested in the CTRP project. To this end, example 7 searches for the EC<sub>50</sub> values for the breast cancer cell lines tested against fulvestrant.</p>
      <p>This query includes a call to the <italic>render</italic> method, which shapes the output into a custom JavaScript Object Notation structure (JSON). In this case, it forms a tuple with the stored sample identifier and EC<sub>50</sub> value. The list of tuples returned by the client can then be passed directly into a Pandas DataFrame.<sup><xref rid="B36" ref-type="bibr">36</xref></sup></p>
      <sec id="s33">
        <title>Query.</title>
        <list list-type="bullet" id="L14">
          <list-item>
            <p>G.query().V(“Program:CTRP”).out(“projects”)</p>
          </list-item>
          <list-item>
            <p>.out(“cases”).out(“samples”).as_(“sample”)</p>
          </list-item>
          <list-item>
            <p>.out(“aliquots”).out(“drug_response”).as_(“response”)</p>
          </list-item>
          <list-item>
            <p>.out(“compounds”).hasId(“Compound:CID104741”)</p>
          </list-item>
          <list-item>
            <p>.render([“$sample._gid”,”$response.submitter_compound_id”,”$response.ec50”])</p>
          </list-item>
        </list>
      </sec>
      <sec id="s34">
        <title>Result.</title>
        <p>The result lists the EC<sub>50</sub> values for each of the <italic>BRCA</italic> cell lines to fulvestrant, connecting the data from CTRP to PubChem entries.</p>
        <list list-type="bullet" id="L15">
          <list-item>
            <p>Sample:CTRP:ACH-000937: fulvestrant (n = 3.075000e−01)</p>
          </list-item>
          <list-item>
            <p>Sample:CTRP:ACH-000076: fulvestrant (n = 2.317000e−02)</p>
          </list-item>
          <list-item>
            <p>Sample:CTRP:ACH-000983: fulvestrant (n = 3.114000e−05)</p>
          </list-item>
          <list-item>
            <p>Sample:CTRP:ACH-000045: fulvestrant (n = 3.055000e−01)</p>
          </list-item>
        </list>
      </sec>
    </sec>
    <sec id="s35">
      <title>Example 8: Find Gene Expression Data Linked to Cell Lines</title>
      <p>Drug response data often are not available for patient samples; thus, machine-learning methods that can use more widely available data, such as gene expression data from RNA sequencing, to predict drug response are highly promising. Example 8 illustrates how associated transcriptomic data can be obtained for the cell lines collected in the previous steps. There is no RNA sequencing available from the CTRP project; however, many of the cell lines were assayed as part of the complementary CCLE project. To identify these samples, example 8 follows the edge connecting the list named <italic>samples</italic> found in example 7 to their parent cases. It then follows the <italic>same_as</italic> edge to identify <italic>Case</italic> vertices in other projects that have overlapping identifiers, and then follows the tree down to the <italic>GeneExpression</italic> node to obtain the expression values. Again, the example uses the <italic>render</italic> function to return properly formatted data structures that can be passed directly into Pandas.</p>
      <sec id="s36">
        <title>Query.</title>
        <list list-type="bullet" id="L16">
          <list-item>
            <p>G.query().V(samples).as_(“sample”)</p>
          </list-item>
          <list-item>
            <p>.out(“case”).out(“same_as”)</p>
          </list-item>
          <list-item>
            <p>.out(“samples”).out(“aliquots”).out(“gene_expressions”).as_(“exp”)</p>
          </list-item>
          <list-item>
            <p>.render([“$sample._gid”, “$exp._data.values”])</p>
          </list-item>
        </list>
      </sec>
      <sec id="s37">
        <title>Result.</title>
        <p>The resulting matrix (<xref rid="T1" ref-type="table">Table 1</xref>) lists the expression values of each gene across cell lines with variants in CTRP and RNA in CCLE. The matrix can be used to develop transcriptome-based drug-response prediction models.<sup><xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B38" ref-type="bibr">38</xref></sup></p>
        <table-wrap id="T1" orientation="portrait" position="float">
          <label>TABLE 1.</label>
          <caption>
            <p>Gene Expression in Transcripts per Million Across Cell Lines With Variants in CTRP</p>
          </caption>
          <graphic xlink:href="CCI.19.00110t1"/>
        </table-wrap>
        <sec id="s38">
          <title>Data Releases.</title>
          <p>The BMEG resource was designed to be portable and open, with multiple ways to access the data (<xref ref-type="fig" rid="f3">Fig 3</xref>). The graph query engine that runs the system is open source and easy to install, and all the compiled source files are made available for bulk download. This will allow other researchers to build on our existing system and to reuse the collected data. We provide translations of the BMEG to make it compatible with a number of different query engines. Part of the BMEG toolkit is a set of scripts to translate the data set and load it into other graph database systems, including Neo4J (San Mateo, CA) and Dgraph (Dgraph Labs, San Francisco, CA).</p>
          <fig id="f3" fig-type="figure" orientation="portrait" position="float">
            <label>FIG 3.</label>
            <caption>
              <p>BioMedical Evidence Graph (BMEG) architecture diagram. (A) The Extract Transform Load (ETL) processes used to build the graph. (B) The database and query engine used to power the bmeg.io site. (C) The different client-side options for communicating with the system. (D) Graph engines that can be used with the BMEG export code to move the BMEG data to other graph databases. GripQL, Graph Integration Platform query language.</p>
            </caption>
            <graphic xlink:href="CCI.19.00110f3"/>
          </fig>
        </sec>
      </sec>
    </sec>
  </sec>
  <sec sec-type="discussion" id="s39">
    <title>DISCUSSION</title>
    <p>Recently, several graph-based data integration projects have appeared, including biograkn,<sup><xref rid="B39" ref-type="bibr">39</xref></sup> Biograph,<sup><xref rid="B40" ref-type="bibr">40</xref></sup> Bio4j (discontinued),<sup><xref rid="B41" ref-type="bibr">41</xref></sup> Bio2RDF,<sup><xref rid="B42" ref-type="bibr">42</xref></sup> and Hetionet.<sup><xref rid="B43" ref-type="bibr">43</xref></sup> Many of these systems were built to aggregate pathway and link genotype to phenotype. The BMEG holds genomic, transcriptomic, and phenotypic data from cancer cases, as well as from cell-line samples, pathway data, genomic descriptions, and extractions from genome-variant knowledge bases. The system includes unit tests composed of built-in Python conversion code, implemented in a Travis continuous integration facility, for technical validation to ensure data are copied and represented accurately. The unique accumulation of various high-quality data types differentiates the BMEG from other data systems. As demonstrated in the example queries, data interrogation can traverse sample mutations, pathway descriptions, knowledge bases, and drug-response data, all within a few lines of query code.</p>
    <p>The fundamental idea of the BMEG is to define a connected data set to enable many possible investigations without the effort needed to collect, normalize, and merge information across disparate systems, thus saving time and effort to focus on research questions rather than data wrangling. Adopting systems like the BMEG will drive analyses that can tap a wide range of sample data, with structured annotations, allowing for a number of feature and prediction label combinations for machine-learning applications to support new pattern discovery.</p>
  </sec>
</body>
<back>
  <fn-group content-type="supported-by">
    <fn specific-use="supported-by" fn-type="supported-by">
      <p>Supported by the National Cancer Institute ITCR program (Grant No. R01CA180778) and funding from the Knight Cancer Institute.</p>
    </fn>
  </fn-group>
  <ack>
    <title>ACKNOWLEDGMENT</title>
    <p>We thank the referees for helpful suggestions.</p>
  </ack>
  <sec id="s40">
    <title>AUTHOR CONTRIBUTIONS</title>
    <p><bold>Conception and design:</bold> Adam Struck, Brian Walsh, Ryan Spangler, Joshua M. Stuart, Kyle Ellrott</p>
    <p><bold>Financial support:</bold> Joshua M. Stuart, Kyle Ellrott</p>
    <p><bold>Collection and assembly of data:</bold> Adam Struck, Brian Walsh, Alexander Buchanan, Ryan Spangler, Joshua M. Stuart, Kyle Ellrott</p>
    <p><bold>Data analysis and interpretation:</bold> Adam Struck, Brian Walsh, Jordan A. Lee, Ryan Spangler, Joshua M. Stuart, Kyle Ellrott</p>
    <p><bold>Manuscript writing:</bold> All authors</p>
    <p><bold>Final approval of manuscript:</bold> All authors</p>
    <p><bold>Accountable for all aspects of the work:</bold> All authors</p>
  </sec>
  <sec sec-type="COI-statement">
    <title>AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST</title>
    <p>The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to <ext-link ext-link-type="uri" xlink:href="http://www.asco.org/rwc">www.asco.org/rwc</ext-link> or <ext-link ext-link-type="uri" xlink:href="http://ascopubs.org/cci/author-center">ascopubs.org/cci/author-center</ext-link>.</p>
    <p>Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (<ext-link ext-link-type="uri" xlink:href="https://openpaymentsdata.cms.gov/">Open Payments</ext-link>).</p>
    <sec id="s42">
      <title>Joshua M. Stuart</title>
      <p><bold>Employment:</bold> ImmunityBio (I)</p>
      <p><bold>Stock and Other Ownership Interests:</bold> Nantomics</p>
      <p><bold>Patents, Royalties, Other Intellectual Property:</bold> Pending patent on CREB1 inhibition for treatment of metastatic prostate cancer</p>
      <p>No other potential conflicts of interest were reported.</p>
    </sec>
  </sec>
  <app-group>
    <app>
      <title>Appendix</title>
      <p>
        <table-wrap id="TA.1" orientation="portrait" position="anchor">
          <label>TABLE A1.</label>
          <caption>
            <p>BioMedical Evidence Graph Data Sources and Their Licenses Used to Build the Graph</p>
          </caption>
          <graphic xlink:href="CCI.19.00110ta1"/>
        </table-wrap>
      </p>
    </app>
  </app-group>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>B-H</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S-K</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S-Y</given-names>
          </name>
        </person-group>
        <article-title>Use of graph database for the integration of heterogeneous biological data</article-title>
        <source>Genomics Inform</source>
        <volume>15</volume>
        <fpage>19</fpage>
        <lpage>27</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">28416946</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Have</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>LJ</given-names>
          </name>
        </person-group>
        <article-title>Are graph databases ready for bioinformatics?</article-title>
        <source>Bioinformatics</source>
        <volume>29</volume>
        <fpage>3107</fpage>
        <lpage>3108</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">24135261</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lysenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Roznovăţ</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Saqi</surname>
            <given-names>M</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Representing and querying disease networks using graph databases</article-title>
        <source>BioData Min</source>
        <volume>9</volume>
        <fpage>23</fpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">27462371</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="web"><person-group person-group-type="author"><name><surname>Ugander</surname><given-names>J</given-names></name><name><surname>Karrer</surname><given-names>B</given-names></name><name><surname>Backstrom</surname><given-names>L</given-names></name><etal>et al</etal></person-group>The anatomy of the Facebook Social Graph. arXiv.1111.4503 [cs.SI]<year>2011</year><ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1111.4503">http://arxiv.org/abs/1111.4503</ext-link></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tatlow</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Piccolo</surname>
            <given-names>SR</given-names>
          </name>
        </person-group>
        <article-title>A cloud-based workflow to quantify transcript-expression levels in public cancer compendia</article-title>
        <source>Sci Rep</source>
        <volume>6</volume>
        <fpage>39259</fpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">27982081</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="other">
        <comment>Lonsdale J, Thomas J, Salvatore M, et al: The Genotype-Tissue Expression (GTEx) project. Nat Genet 45:580-585, 2013</comment>
      </mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="other">
        <comment>Boutros PC, Ewing AD, Ellrott K, et al: Global optimization of somatic variant identification in cancer genomes with a global community challenge. Nat Genet 46:318-319, 2014</comment>
      </mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ellrott</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bailey</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Saksena</surname>
            <given-names>G</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines</article-title>
        <source>Cell Syst</source>
        <volume>6</volume>
        <fpage>271</fpage>
        <lpage>281.e7</lpage>
        <year>2018</year>
        <pub-id pub-id-type="pmid">29596782</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mermel</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Schumacher</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>B</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers</article-title>
        <source>Genome Biol</source>
        <volume>12</volume>
        <fpage>R41</fpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21527027</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ghandi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>FW</given-names>
          </name>
          <name>
            <surname>Jané-Valbuena</surname>
            <given-names>J</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Next-generation characterization of the Cancer Cell Line Encyclopedia</article-title>
        <source>Nature</source>
        <volume>569</volume>
        <fpage>503</fpage>
        <lpage>508</lpage>
        <year>2019</year>
        <pub-id pub-id-type="pmid">31068700</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Smirnov</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kofia</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Maru</surname>
            <given-names>A</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>PharmacoDB: An integrative database for mining in vitro anticancer drug screening studies</article-title>
        <source>Nucleic Acids Res</source>
        <volume>46</volume>
        <fpage>D994</fpage>
        <lpage>D1002</lpage>
        <year>2018</year>
        <pub-id pub-id-type="pmid">30053271</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal">
        <comment>Barretina J, Caponigro G, Stransky N, et al: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603-607, 2012 [Addendum: Nature 565:E5-E6, 2019]</comment>
      </mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Basu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bodycombe</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Cheah</surname>
            <given-names>JH</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules</article-title>
        <source>Cell</source>
        <volume>154</volume>
        <fpage>1151</fpage>
        <lpage>1161</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23993102</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rees</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Seashore-Ludlow</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cheah</surname>
            <given-names>JH</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Correlating chemical sensitivity and basal gene expression reveals mechanism of action</article-title>
        <source>Nat Chem Biol</source>
        <volume>12</volume>
        <fpage>109</fpage>
        <lpage>116</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">26656090</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Soares</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>P</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells</article-title>
        <source>Nucleic Acids Res</source>
        <volume>41</volume>
        <fpage>D955</fpage>
        <lpage>D961</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23180760</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van der Meer</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Barthorpe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models</article-title>
        <source>Nucleic Acids Res</source>
        <volume>47</volume>
        <fpage>D923</fpage>
        <lpage>D929</lpage>
        <year>2019</year>
        <pub-id pub-id-type="pmid">30260411</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="web">
        <person-group person-group-type="author">
          <name>
            <surname>Wagner</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Walsh</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Mayfield</surname>
            <given-names>G</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <comment>A harmonized meta-knowledgebase of clinical interpretations of cancer genomic variants. bioRxiv 366856</comment>
        <year>2018</year>
        <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/366856v2">https://www.biorxiv.org/content/10.1101/366856v2</ext-link>
      </mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cerami</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Gross</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Demir</surname>
            <given-names>E</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Pathway Commons, a web resource for biological pathway data</article-title>
        <source>Nucleic Acids Res</source>
        <volume>39</volume>
        <fpage>D685</fpage>
        <lpage>D690</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21071392</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fabregat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jupe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>L</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Reactome Pathway Knowledgebase</article-title>
        <source>Nucleic Acids Res</source>
        <volume>46</volume>
        <fpage>D649</fpage>
        <lpage>D655</lpage>
        <year>2018</year>
        <pub-id pub-id-type="pmid">29145629</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schaefer</surname>
            <given-names>CF</given-names>
          </name>
          <name>
            <surname>Anthony</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Krupa</surname>
            <given-names>S</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>PID: the Pathway Interaction Database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>37</volume>
        <fpage>D674</fpage>
        <lpage>D679</lpage>
        <year>2009</year>
        <issue>suppl 1</issue>
        <pub-id pub-id-type="pmid">18832364</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hornbeck</surname>
            <given-names>PV</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>B</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations</article-title>
        <source>Nucleic Acids Res</source>
        <volume>43</volume>
        <fpage>D512</fpage>
        <lpage>D520</lpage>
        <year>2015</year>
        <pub-id pub-id-type="pmid">25514926</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Romero</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wagg</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>ML</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Computational prediction of human metabolic pathways from the complete human genome</article-title>
        <source>Genome Biol</source>
        <volume>6</volume>
        <fpage>R2</fpage>
        <year>2005</year>
        <pub-id pub-id-type="pmid">15642094</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Muruganujan</surname>
            <given-names>A</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>PANTHER version 11: Expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements</article-title>
        <source>Nucleic Acids Res</source>
        <volume>45</volume>
        <fpage>D183</fpage>
        <lpage>D189</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">27899595</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tamayo</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mootha</surname>
            <given-names>VK</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles</article-title>
        <source>Proc Natl Acad Sci USA</source>
        <volume>102</volume>
        <fpage>15545</fpage>
        <lpage>15550</lpage>
        <year>2005</year>
        <pub-id pub-id-type="pmid">16199517</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thiele</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Swainston</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Fleming</surname>
            <given-names>RMT</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>A community-driven global reconstruction of human metabolism</article-title>
        <source>Nat Biotechnol</source>
        <volume>31</volume>
        <fpage>419</fpage>
        <lpage>425</lpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23455439</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Davis</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Grondin</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>RJ</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Comparative Toxicogenomics Database: Update 2017</article-title>
        <source>Nucleic Acids Res</source>
        <volume>45</volume>
        <fpage>D972</fpage>
        <lpage>D978</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">27651457</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wrzodek</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Büchel</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ruff</surname>
            <given-names>M</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Precise generation of systems biology models from KEGG pathways</article-title>
        <source>BMC Syst Biol</source>
        <volume>7</volume>
        <fpage>15</fpage>
        <year>2013</year>
        <pub-id pub-id-type="pmid">23433509</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yamamoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sakai</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>H</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>INOH: Ontology-based highly structured database of signal transduction pathways</article-title>
        <source>Database (Oxford)</source>
        <volume>2011</volume>
        <elocation-id>bar052</elocation-id>
        <year>2011</year>
        <pub-id pub-id-type="pmid">22120663</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kandasamy</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mohan</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Raju</surname>
            <given-names>R</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>NetPath: A public resource of curated signal transduction pathways</article-title>
        <source>Genome Biol</source>
        <volume>11</volume>
        <fpage>R3</fpage>
        <year>2010</year>
        <pub-id pub-id-type="pmid">20067622</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pico</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Kelder</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>van Iersel</surname>
            <given-names>MP</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>WikiPathways: Pathway editing for the people</article-title>
        <source>PLoS Biol</source>
        <volume>6</volume>
        <elocation-id>e184</elocation-id>
        <year>2008</year>
        <pub-id pub-id-type="pmid">18651794</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hubbard</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Birney</surname>
            <given-names>E</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Ensembl genome database project</article-title>
        <source>Nucleic Acids Res</source>
        <volume>30</volume>
        <fpage>38</fpage>
        <lpage>41</lpage>
        <year>2002</year>
        <pub-id pub-id-type="pmid">11752248</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McLaren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Gil</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hunt</surname>
            <given-names>SE</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Ensembl variant effect predictor</article-title>
        <source>Genome Biol</source>
        <volume>17</volume>
        <fpage>122</fpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">27268795</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Finn</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Clements</surname>
            <given-names>J</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Pfam: The protein families database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D222</fpage>
        <lpage>D230</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24288371</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="other">
        <comment>Carbon S, Mungall C: Gene Ontology Data Archive. 2018.</comment>
      </mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="web">
        <comment>Rodriguez MA: The Gremlin Graph Traversal Machine and Language. arXiv:1508.03843 [cs.DB]. 2015</comment>
        <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1508.03843">http://arxiv.org/abs/1508.03843</ext-link>
      </mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>W</given-names></name></person-group><article-title>Data structures for statistical computing in python</article-title>in<source>Proceedings of the 9th Python in Science Conference</source><conf-loc>Austin, TX</conf-loc><year>2010</year><fpage>51</fpage><lpage>56</lpage></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sakellaropoulos</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vougas</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Narang</surname>
            <given-names>S</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>A deep learning framework for predicting response to therapy in cancer</article-title>
        <source>Cell Rep</source>
        <volume>29</volume>
        <fpage>3367</fpage>
        <lpage>3373.e4</lpage>
        <year>2019</year>
        <pub-id pub-id-type="pmid">31825821</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Costello</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Heiser</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Georgii</surname>
            <given-names>E</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>A community effort to assess and improve drug sensitivity prediction algorithms</article-title>
        <source>Nat Biotechnol</source>
        <volume>32</volume>
        <fpage>1202</fpage>
        <lpage>1212</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24880487</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="book">
        <comment>Messino A, Pribadi H, Stichbury J: BioGrakn: A knowledge graph-based semantic database for biomedical sciences, in Barolli K, Terzo O, eds: Complex, Intelligent, and Software Intensive Systems. New York, NY, Springer International Publishing, 2018:299-309</comment>
      </mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Messina</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fiannaca</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>La Paglia</surname>
            <given-names>L</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>BioGraph: A web application and a graph database for querying and analyzing bioinformatics resources</article-title>
        <source>BMC Syst Biol</source>
        <volume>12</volume>
        <fpage>98</fpage>
        <year>2018</year>
        <pub-id pub-id-type="pmid">30458802</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="other">
        <comment>Reference deleted</comment>
      </mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Belleau</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nolin</surname>
            <given-names>M-A</given-names>
          </name>
          <name>
            <surname>Tourigny</surname>
            <given-names>N</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Bio2RDF: Towards a mashup to build bioinformatics knowledge systems</article-title>
        <source>J Biomed Inform</source>
        <volume>41</volume>
        <fpage>706</fpage>
        <lpage>716</lpage>
        <year>2008</year>
        <pub-id pub-id-type="pmid">18472304</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="other">
        <comment>Reference deleted</comment>
      </mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flicek</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Amode</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Barrell</surname>
            <given-names>D</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Ensembl 2011</article-title>
        <source>Nucleic Acids Res</source>
        <volume>39</volume>
        <fpage>D800</fpage>
        <lpage>D806</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21045057</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ashburner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ball</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Blake</surname>
            <given-names>JA</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Gene ontology: Tool for the unification of biology</article-title>
        <source>Nat Genet</source>
        <volume>25</volume>
        <fpage>25</fpage>
        <lpage>29</lpage>
        <year>2000</year>
        <pub-id pub-id-type="pmid">10802651</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mungall</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>McMurry</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Köhler</surname>
            <given-names>S</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Monarch Initiative: An integrative data and analytic platform connecting phenotypes to genotypes across species</article-title>
        <source>Nucleic Acids Res</source>
        <volume>45</volume>
        <fpage>D712</fpage>
        <lpage>D722</lpage>
        <year>2017</year>
        <pub-id pub-id-type="pmid">27899636</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liberzon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pinchback</surname>
            <given-names>R</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Molecular signatures database (MSigDB) 3.0</article-title>
        <source>Bioinformatics</source>
        <volume>27</volume>
        <fpage>1739</fpage>
        <lpage>1740</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21546393</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>El-Gebali</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mistry</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Pfam protein families database in 2019</article-title>
        <source>Nucleic Acids Res</source>
        <volume>47</volume>
        <fpage>D427</fpage>
        <lpage>D432</lpage>
        <year>2019</year>
        <pub-id pub-id-type="pmid">30357350</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thiessen</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Bolton</surname>
            <given-names>EE</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>PubChem substance and compound databases</article-title>
        <source>Nucleic Acids Res</source>
        <volume>44</volume>
        <fpage>D1202</fpage>
        <lpage>D1213</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">26400175</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bader</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>Betel</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hogue</surname>
            <given-names>CWV</given-names>
          </name>
        </person-group>
        <article-title>BIND: The Biomolecular Interaction Network Database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>31</volume>
        <fpage>248</fpage>
        <lpage>250</lpage>
        <year>2003</year>
        <pub-id pub-id-type="pmid">12519993</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stark</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Breitkreutz</surname>
            <given-names>B-J</given-names>
          </name>
          <name>
            <surname>Reguly</surname>
            <given-names>T</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>BioGRID: A general repository for interaction datasets</article-title>
        <source>Nucleic Acids Res</source>
        <volume>34</volume>
        <fpage>D535</fpage>
        <lpage>D539</lpage>
        <year>2006</year>
        <pub-id pub-id-type="pmid">16381927</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giurgiu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Reinhard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Brauner</surname>
            <given-names>B</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>CORUM: The comprehensive resource of mammalian protein complexes-2019</article-title>
        <source>Nucleic Acids Res</source>
        <volume>47</volume>
        <fpage>D559</fpage>
        <lpage>D563</lpage>
        <year>2019</year>
        <pub-id pub-id-type="pmid">30357367</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Salwinski</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>AJ</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The Database of Interacting Proteins: 2004 Update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>32</volume>
        <fpage>D449</fpage>
        <lpage>D451</lpage>
        <year>2004</year>
        <pub-id pub-id-type="pmid">14681454</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keshava Prasad</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Goel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kandasamy</surname>
            <given-names>K</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Human Protein Reference Database–2009 update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>37</volume>
        <fpage>D767</fpage>
        <lpage>D772</lpage>
        <year>2009</year>
        <pub-id pub-id-type="pmid">18988627</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Orchard</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ammari</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aranda</surname>
            <given-names>B</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The MIntAct project–IntAct as a common curation platform for 11 molecular interaction databases</article-title>
        <source>Nucleic Acids Res</source>
        <volume>42</volume>
        <fpage>D358</fpage>
        <lpage>D363</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24234451</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cotto</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y-Y</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>DGIdb 3.0: A redesign and expansion of the drug-gene interaction database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>46</volume>
        <fpage>D1068</fpage>
        <lpage>D1073</lpage>
        <year>2018</year>
        <pub-id pub-id-type="pmid">29156001</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Isserlin</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bader</surname>
            <given-names>GD</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Too many roads not taken</article-title>
        <source>Nature</source>
        <volume>470</volume>
        <fpage>163</fpage>
        <lpage>165</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21307913</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bento</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hersey</surname>
            <given-names>A</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The ChEMBL bioactivity database: An update</article-title>
        <source>Nucleic Acids Res</source>
        <volume>42</volume>
        <fpage>D1083</fpage>
        <lpage>D1090</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24214965</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ainscough</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Griffith</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Coffman</surname>
            <given-names>AC</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>DoCM: A database of curated mutations in cancer</article-title>
        <source>Nat Methods</source>
        <volume>13</volume>
        <fpage>806</fpage>
        <lpage>807</lpage>
        <year>2016</year>
        <pub-id pub-id-type="pmid">27684579</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pawson</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Sharman</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Benson</surname>
            <given-names>HE</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>The IUPHAR/BPS Guide to Pharmacology: An expert-driven knowledgebase of drug targets and their ligands</article-title>
        <source>Nucleic Acids Res</source>
        <volume>42</volume>
        <fpage>D1098</fpage>
        <lpage>D1106</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24234439</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Simon</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Somaiah</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer</article-title>
        <source>Clin Lung Cancer</source>
        <volume>15</volume>
        <fpage>21</fpage>
        <lpage>51</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24377743</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rask-Andersen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Masuram</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schiöth</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication</article-title>
        <source>Annu Rev Pharmacol Toxicol</source>
        <volume>54</volume>
        <fpage>9</fpage>
        <lpage>26</lpage>
        <year>2014</year>
        <pub-id pub-id-type="pmid">24016212</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rask-Andersen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Almén</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Schiöth</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Trends in the exploitation of novel drug targets</article-title>
        <source>Nat Rev Drug Discov</source>
        <volume>10</volume>
        <fpage>579</fpage>
        <lpage>590</lpage>
        <year>2011</year>
        <pub-id pub-id-type="pmid">21804595</pub-id>
      </mixed-citation>
    </ref>
    <ref id="B64">
      <label>64.</label>
      <mixed-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>P</given-names>
          </name>
          <etal>et al</etal>
        </person-group>
        <article-title>Update of TTD: Therapeutic target database</article-title>
        <source>Nucleic Acids Res</source>
        <volume>38</volume>
        <fpage>D787</fpage>
        <lpage>D791</lpage>
        <year>2010</year>
        <issue>suppl 1</issue>
        <pub-id pub-id-type="pmid">19933260</pub-id>
      </mixed-citation>
    </ref>
  </ref-list>
</back>
